Clinical Trials Browser

Interventional × Radiation Dose Hypofractionation × 30 days × Clear all

NCT03570827 2026-05-26

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Phase 2 Completed

53 enrolled 11 charts

Prostatic Neoplasms

NCT07605507 2026-05-26

HYPOCx-iRex

Phase NA Active not recruiting

Uterine Cervical Neoplasms

NCT04172532 2026-05-22

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03274687 2026-05-20

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Phase 3 Completed

296 enrolled 29 charts

Prostate Adenocarcinoma

NCT03987386 2026-05-20

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT07595224 2026-05-19

PostOP HYPOCxE

Phase NA Recruiting

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03624478 2026-05-15

Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery

Phase 2 Completed

25 enrolled 11 charts

Anatomic Stage I Breast Cancer AJCC v8

NCT04068194 2026-05-13

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Phase 1/2 Active not recruiting

Gastrointestinal

Gallbladder Neoplasms, Neoplasm Metastasis, Cholangiocarcinoma

NCT04310020 2026-05-13

Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03972930 2026-05-12

Hypofractionated Radiotherapy for Soft Tissue Sarcomas

Phase 2 Active not recruiting

48 enrolled 10 charts

Sarcoma

NCT04106856 2026-05-12

SHAPER

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07188532 2026-05-11

BEAR

Phase NA Recruiting

Sarcoma, Ewing

NCT07566156 2026-05-11

EV-309

Phase 3 Recruiting

Urogenital Diseases, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Female Urogenital Diseases, Male Urogenital Diseases

NCT03486821 2026-05-05

Ultra-hypofractionated Radiation in Prostate Cancer

Phase NA Completed

Financial Stress

NCT07097142 2026-05-04

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Phase 3 Recruiting

Urinary Bladder Neoplasms